Corcept Therapeutics Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-20.2M | $-20.1M | $-11.6M | $-24.9M | $-20.1M | $-15.5M | $-9.8M | $-18.5M |
| Depreciation & Amortization | $10.0K | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.8M | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-18.0M | — | — | — | — | — | — | — |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $3.6M | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $23.5M | — | — | — | — | — | — | — |
| Net Change in Cash | $9.2M | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |